<?xml version="1.0" encoding="utf-8"?>
<DATASETS>
	<DATASET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" alias="RECA-EU_PCAWG_WGS_BWA" center_name="ICGC" broker_name="EGA" accession="EGAD00001002131">
		<TITLE>ICGC PCAWG Dataset: RECA-EU_PCAWG_WGS_BWA</TITLE>
		<DESCRIPTION>ICGC PCAWG Dataset for WGS BAM aligned using BWA MEM. Project: RECA-EU.</DESCRIPTION>
		<ANALYSIS_REF accession="EGAZ00001226148"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226167"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224064"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226178"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224060"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226239"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226214"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226209"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226186"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224011"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224076"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226161"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224009"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224041"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226221"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226145"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226207"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224079"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226223"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226170"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226157"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224066"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224055"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224039"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226189"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226220"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226173"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226175"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224017"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224019"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226158"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226190"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226228"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224063"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226150"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226155"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224030"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226162"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224024"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224015"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226171"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224056"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226227"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224058"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226151"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224045"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224018"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226229"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226191"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226164"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224025"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226129"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226226"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226231"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226154"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224023"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226230"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226197"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224077"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226172"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226208"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226213"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226159"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226216"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226235"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224014"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226219"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226146"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224048"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224071"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226174"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226237"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226131"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224073"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226147"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224044"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224068"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226232"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226144"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224043"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224026"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226135"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226212"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224036"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226196"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226180"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226202"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226194"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226233"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224008"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226163"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226236"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226181"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226238"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226215"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224006"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224038"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224047"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224050"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224013"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224035"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226143"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224040"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226132"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224078"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224021"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226183"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224022"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226184"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224037"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224046"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226218"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226182"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224010"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226206"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226224"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226153"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226198"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226217"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224054"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224020"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226210"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226211"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224051"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224065"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224049"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226128"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224072"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226149"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224074"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224029"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224062"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224031"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226152"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226125"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226127"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226168"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224052"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224032"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226138"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226201"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226136"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224034"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226205"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224069"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226142"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224007"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224059"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226225"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226222"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226165"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226187"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226203"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226160"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224033"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226204"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224027"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224080"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226200"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226185"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226133"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226141"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224075"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226193"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226137"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224057"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226134"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226179"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224012"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226139"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226169"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224042"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226126"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226199"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224067"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226188"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226234"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226176"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224061"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226166"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226140"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224053"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226156"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224028"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224016"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001224070"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226177"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226130"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226192"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001226195"></ANALYSIS_REF>
		<POLICY_REF accession="EGAP00001000011" refname="ICGC Data Access Agreements" refcenter="ICGC">
			<IDENTIFIERS>
				<PRIMARY_ID>EGAP00001000011</PRIMARY_ID>
				<SUBMITTER_ID namespace="ICGC">ICGC Data Access Agreements</SUBMITTER_ID>
			</IDENTIFIERS>
		</POLICY_REF>
		<DATASET_LINKS>
			<DATASET_LINK>
				<URL_LINK>
					<LABEL>ICGC Data Portal</LABEL>
					<URL>http://dcc.icgc.org</URL>
				</URL_LINK>
			</DATASET_LINK>
		</DATASET_LINKS>
	</DATASET>
</DATASETS>